Trial
NCT04221061
18F-FluorThanatrace (PET/CT) in Glioblastoma
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Glioblastoma
Intervention
18F-FluorThanatrace
Why stopped
Companion treatment trial closed early with negative results. No imaging study participants completed the full study imaging planned due to logistical difficulties.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-17